Neteera

Neteera is an Israeli startup founded in 2015 that has developed an FDA-cleared contactless patient monitoring platform designed to enable continuous monitoring of patients' biomarkers without the need for contact or patient involvement. The company's sensing technology is based on a safe, maintenance-free, sub-terahertz micro-radar-on-chip sensor solution that protects privacy as it is not camera-based.

Neteera's platform improves patient care and operational efficiencies by eliminating the need for device manipulation, removal of clothing, and caregiver presence during monitoring. The technology has proven product-market fit for addressing challenges faced by healthcare systems globally and enabling optimal patient comfort.

In April 2023, Neteera secured around USD 13 million in Series B funding led by Aescuvest, alongside other investors including Omega healthcare Investors. This funding allowed the company to accelerate sales, production, and deployment of its solution, as well as further develop its proprietary medical sensing platform.

In October 2023, Neteera raised an additional USD 6.7 million in a Series B extension round, again led by Aescuvest and joined by Foxconn Technology. The new funding expedited production to meet increasing demand, supported recruitment of installation and deployment personnel, and solidified Neteera's leadership in the contactless patient monitoring market. Notably, the partnership with Foxconn enabled mass production of Neteera's products.

Key customers and partnerships

In 2023, Neteera began selling its contactless patient monitoring platform to a large number of long-term care facilities in the US, with a significant pipeline of ordered products currently being deployed.

The company also entered into a strategic partnership with Omega healthcare Investors, a leading US-based healthcare REIT, to offer Neteera's technology to Omega's network of long-term care and skilled nursing facilities across the US and the UK.